Skip to main content

HomeResearchCortagen

CategoryLongevity
SafetyLow Risk
StatusResearch Only

Cortagen

vascular peptide bioregulator · cardiovascular Khavinson peptide · vessel cytomax

CategoryLongevity
Half-life
Routeoral, subcutaneous
RiskLow Risk
ProvidersNone listed

About Cortagen

Vascular-targeted peptide complex that modulates endothelial cell gene expression. May support nitric oxide production, reduce vascular inflammation, and improve endothelial function.

A short peptide bioregulator derived from blood vessel tissue, developed by the Khavinson Institute. Studied for cardiovascular function support and mitigation of age-related vascular deterioration.

Research Areas

cardiovascular supportvascular healthendothelial functionlongevity

Regulatory & Evidence

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Low Risk

Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.

Reported contraindications & considerations

Cardiovascular ConditionPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find Cortagen

Coverage expanding

No verified providers currently list Cortagen. Get notified when one does, or explore providers carrying similar peptides in the Longevity category.

Frequently Asked Questions — Cortagen

A short peptide bioregulator derived from blood vessel tissue, developed by the Khavinson Institute. Studied for cardiovascular function support and mitigation of age-related vascular deterioration.

cardiovascular support, vascular health, endothelial function, longevity, anti-aging.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.